Theralase Technologies Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CAD 0.34078 million compared to CAD 0.305216 million a year ago. Net loss was CAD 1.25 million compared to CAD 1.14 million a year ago. Basic loss per share from continuing operations was CAD 0.006 compared to CAD 0.006 a year ago.
For the six months, sales was CAD 0.552442 million compared to CAD 0.429999 million a year ago. Net loss was CAD 2.95 million compared to CAD 2.06 million a year ago. Basic loss per share from continuing operations was CAD 0.014 compared to CAD 0.01 a year ago.